Covered recipient · General Payments record
KENDALL BISHOP
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023
$203.03
- Reported across 9 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $203.03 | 9 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Neurocrine BioSciences, Inc. | $48.97 | 2 |
| Lilly USA, LLC | $40.75 | 2 |
| EMD Serono, Inc. | $35.62 | 1 |
| Octapharma USA, Inc. | $24.97 | 1 |
| TG THERAPEUTICS, INC. | $20.33 | 1 |
| Celgene Corporation | $17.53 | 1 |
| Sumitomo Pharma America, Inc. | $14.86 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2023 | $203.03 | 9 |
Payment records · PY2023 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Celgene Corporation | $17.53 | 07/11/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1015850729 | CMS |
| EMD Serono, Inc. | $35.62 | 06/24/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1032424073 | CMS |
| Lilly USA, LLC | $26.68 | 06/13/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1033126627 | CMS |
| Lilly USA, LLC | $14.07 | 06/23/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1033157163 | CMS |
| Neurocrine Biosciences, Inc. | $23.98 | 06/27/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1052327659 | CMS |
| Neurocrine Biosciences, Inc. | $24.99 | 07/19/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1052327739 | CMS |
| Octapharma USA, Inc. | $24.97 | 07/18/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1042740099 | CMS |
| Sumitomo Pharma America, Inc. | $14.86 | 06/09/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1031183997 | CMS |
| TG Therapeutics, Inc. | $20.33 | 07/17/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1051488519 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2023
- Source files
- Dataset page · Bulk file · PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.